Company Filing History:
Years Active: 2022
Title: The Innovations of Inventor Xiao-Fen Wang
Introduction
Xiao-Fen Wang, a notable inventor based in San Diego, CA, has made significant contributions to the field of immunology. With a focus on innovative methods of detecting human IL-21, Wang's work has implications for diagnostics and therapeutic regimens.
Latest Patents
Wang holds a patent titled "Methods of detecting human IL-21." This patent includes antibodies or antigen-binding fragments that specifically bind to human IL-21, facilitating immunoassays for determining IL-21 levels. The antibodies developed by Wang are valuable for diagnostic, prognostic, and predictive applications, especially in the context of diseases where IL-21 signaling plays a critical role in pathogenesis.
Career Highlights
Currently, Wang is employed at Eli Lilly and Company, where she continues her research and development efforts. Her expertise has allowed her to advance scientific understanding in her area, contributing to the evolving field of immunological diagnostics.
Collaborations
Wang collaborates with distinguished colleagues, including Stuart W. Bright and Julian Davies. These partnerships enhance her research capabilities and expand the impact of her innovations within the scientific community.
Conclusion
Xiao-Fen Wang's dedication to innovation in the detection of human IL-21 highlights the vital role of inventors in the healthcare and biotechnology sector. Her work not only furthers scientific inquiry but also paves the way for improved diagnostic methods and therapeutic strategies for patients affected by conditions related to IL-21 signaling.